SCHEMBL21986848

SCHEMBL21986848

COC(=O)c1c(OC)ccc2nnn(C3CCCCO3)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.39
▸ HPGD P15428 4/20 0.39
▸ KDM4E B2RXH2 4/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ ATR Q13535 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ POLQ O75417 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21986911 0.88 CYP4F2 (0.38) ALDH1A1HPGDKDM4ESMN1; SMN2HSD17B10
SCHEMBL21986713 0.87 SLC6A3 (0.38) ALDH1A1HPGDKDM4ESMN1; SMN2HSD17B10
SCHEMBL21986760 0.83 MAPT (0.38) ALDH1A1HPGDKDM4ESMN1; SMN2HSD17B10
SCHEMBL21986706 0.81 ALDH1A1 (0.35) ALDH1A1HPGDHSD17B10MAPTTP53
SCHEMBL21986838 0.79 ALDH1A1 (0.35) ALDH1A1HPGDMAPTTP53ATR
SCHEMBL21986791 0.78 ALDH1A1 (0.36) ALDH1A1HPGDKDM4ESMN1; SMN2HSD17B10
SCHEMBL21986898 0.72 SLC6A3 (0.39) HPGDMAPTNPC1RAB9AATR
SCHEMBL21986732 0.72 CYP4F2 (0.38) ALDH1A1HPGDSMN1; SMN2MAPTTP53
SCHEMBL21986748 0.70 CYP4F2 (0.39) ALDH1A1KDM4ESMN1; SMN2TP53L3MBTL1
SCHEMBL23629483 0.70 RXRA (0.40) ALDH1A1HPGDKDM4ESMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3660003-B1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2024-01-24 — — EP disclosed
US-11713311-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-08-01 — — US disclosed
US-20220388995-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2022-12-08 — — US disclosed
US-11230541-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2022-01-25 — — US disclosed
US-20200231579-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-07-23 — — US disclosed
EP-3660003-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2020-06-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11230541-B2 Heterocyclic compound GRIN1, GRIN2A, GRIN2B ALDH1A1 3354/4885HPGD 443/4885KDM4E 3433/4885
US-20200231579-A1 HETEROCYCLIC COMPOUND GRIN1, GRIN2A, GRIN2B ALDH1A1 3354/4885HPGD 443/4885KDM4E 3433/4885
US-11713311-B2 Heterocyclic compound GRIN1, GRIN2A, GRIN2B ALDH1A1 3354/4885HPGD 443/4885KDM4E 3433/4885
US-20220388995-A1 HETEROCYCLIC COMPOUND GRIN1, GRIN2A, GRIN2B ALDH1A1 3354/4885HPGD 443/4885KDM4E 3433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback